Assessment and prognostic analysis of EGFR mutations or/and HER2 overexpression in Uygur's Non-small Cell Lung Cancer.

about

Celecoxib-erlotinib combination delays growth and inhibits angiogenesis in EGFR-mutated lung cancer.Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway.

P2860

Q37143937-ED7BABD2-443B-4138-A27F-22808381ADF8 Q52649720-C3221758-103C-4366-A1F9-5C9872A717E8

P2860

Assessment and prognostic analysis of EGFR mutations or/and HER2 overexpression in Uygur's Non-small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q36511496

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@ast

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@en

type

Item

label

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@ast

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@en

prefLabel

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@ast

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@en

P1476

Assessment and prognostic anal ...... 's Non-small Cell Lung Cancer.

@en

P2093

Chunli Jia

http://www.w3.org/2001/XMLSchema#string

Guoli Du

http://www.w3.org/2001/XMLSchema#string

Hongli Shen

http://www.w3.org/2001/XMLSchema#string

Jianling Bao

http://www.w3.org/2001/XMLSchema#string

Li Shan

http://www.w3.org/2001/XMLSchema#string

Qin Yu

http://www.w3.org/2001/XMLSchema#string

Xuelin Liang

http://www.w3.org/2001/XMLSchema#string

Zhonghua Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials

Structural, Biochemical, and Clinical Characterization of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations in Lung Cancer

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cancer statistics, 2006

Screening for epidermal growth factor receptor mutations in lung cancer

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data.

Spectrum of LKB1, EGFR, and KRAS mutations in chinese lung adenocarcinomas.

The role of human epidermal growth factor receptor 2 as a prognostic factor in lung cancer: a meta-analysis of published data.

P304

22300-22309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26885207

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

4729993

http://www.w3.org/2001/XMLSchema#string

Assessment and prognostic analysis of EGFR mutations or/and HER2 overexpression in Uygur's Non-small Cell Lung Cancer.

about

P2860

P2860

Assessment and prognostic analysis of EGFR mutations or/and HER2 overexpression in Uygur's Non-small Cell Lung Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P921

P932